What's Happening

Stay up to date on conferences, social posts, and what’s new with Healthesystems

Events

Let’s connect at one of our upcoming conferences or speaking engagements

MedMonitor

An up-to-date timeline of FDA approvals that could impact workers' comp
View All MedMonitor Information

Riabni (rituximab-arrx)

Approval Date: Jun 2022

Note: New Indication

A biosimilar to Rituxan® with existing oncology indications, this drug is now approved for the treatment of moderate-to-severe rheumatoid arthritis, in combination with methotrexate.

hello world!

Skyrizi® (risankizumab-rzza) injection

Approval Date: Jun 2022

Note: New Indication

Approved for its third indication for moderately to severely active Crohn’s disease, in addition to existing indications for moderate-to-severe plaque psoriasis and active psoriatic arthritis.

hello world!

Vtama® (tapinarof) cream

Approval Date: May 2022

Note: New Product

A steroid-free topical indicated for treatment of plaque psoriasis

hello world!

Olumiant® (baricitinib)

Approval Date: May 2022

Note: New Product

Indicated for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, and other assistance with breathing

hello world!

Mounjaro (tirzepatide) injection

Approval Date: May 2022

Note: New Product

Indicated for the improvement of glycemic control in patients with type 2 diabetes, in conjunction with diet and exercise

hello world!

Igalmi (dexmedetomidine) sublingual film

Approval Date: Apr 2022

Note: New Product

Indicated for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder

hello world!

Vimpat (lacosamide) tablets

Approval Date: Mar 2022

Note: First-Time Generic

A first-time generic for Vimpat, this drug treats partial onset seizures

hello world!

Adlarity (donepezil hydrochloride) transdermal system

Approval Date: Mar 2022

Note: New Product

Indicated for the treatment of mild-to-severe dementia of the Alzheimer’s type. This product is the first transdermal patch for this indication.

hello world!

Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol

Approval Date: Mar 2022

Note: First-Time Generic

A first-time generic for Symbicort, this drug is indicated for the treatment of COPD and asthma.

hello world!

Farxiga (dapgliflozin) tablets

Approval Date: Feb 2022

Note: First-Time Generic

A first-time generic for Farxiga, a medication used to treat type 2 diabetes, as well as adults with certain kinds of heart failure chronic kidney disease.

hello world!
1 5 6 7 8 9 12

Social Hub

Check out our latest posts and activity
View All Social Media
    lockenvelopephone-handsetmagnifiermenucross-circle